Michael Hammerschmid Email & Phone Number

Vienna, Austria

Transform Science’s mission is to transform excellent scientific ideas into rewarding independent business concepts. We support innovative projects and start up companies and resume all arising management tasks. Our approach offers scientific experts the chance to focus on their specific expertise. Transform Science is a partner that develops strategies, carries out concrete tasks and keeps track of the big picture.

Wien, Österreich

AURIMOD is a 2015 founded start-up launched by a highly experienced and interdisciplinary team from academia, medicine and engineering. We focus on product development and applied biomedical/clinical research in the field of wearable electro-medical devices for percutaneous auricular vagus nerve stimulation.We develop innovative therapies for personalized pain management based on electrical stimulation. The targeted stimulation modulates sensory fibers of the vagus nerve in the ear. This minimal-invasive pain therapy has successfully been proven its clinical efficacy and effectiveness.Auricular vagus nerve stimulation is a non-pharmacological pain treatment with sustainable effects. Our highly innovative concept of stimulation allows for an optimized and individual therapy even for otherwise treatment resistant patients.

Wien

Syconium Lactic Acid GmbH (SLA) has the goal to develop a production process for lactic acid operating at significantly lower costs compared to currently established production processes. Therefore SLA combines the newest knowhow in metabolic engineering and genetics of yeast strains with innovative approaches in bioprocess engineering to maximize the production rate of lactic acid. The product of SLA is a novel proprietary production solution for lactic acid composed of a novel yeast strain and an aligned production process. SLA sees itself as a link between cutting edge scientific innovation and the large-scale industrial production.

Wien, Österreich

Head of Quality Support and Deputy Head of Quality Austria; Currently responsible for the following units: Monitoring and Sampling Services, Product Support, Stability Office Computer Services In addition responsible for several internal projects and international customer projects e.g. implementation of Laboratory Information and Management System (LIMS), optimization of business processes.Budget responsibilityresponsible for 31 employeessince June 2008: „Kontrolllaborleiter für die Biotechnologische Produktion“ acc. To Austrian law „Arzneimittelgesetzt (AMG), BGBl. Nr. 185/1983, BGBl. I Nr. 153/2005, in Verbindung mit der auf Basis des §70 Abs. 2 AMG erlassenen Verordnung der Bundesministerin für Gesundheit und Frauen über die wissenschaftliche Berufsvorbildung und praktische Ausbildung einer Person, die mit der Leitung eines Kontrolllabors betraut ist (KLVO 2005), BGBl. II Nr. 480/2004“Since September 2003: Head of different Quality Control TeamsResponsible for several analytical laboratories (Water Testing (TOC), Microbiology, In process control, Raw material incoming testing) Monitoring and Sampling Service within the Quality Control and Quality Management department

Vienna, Austria

Head of business processes: oligonucleotide production, sequencing service, biochip production and services. Registration of a legal production permit (Betriebsanlagengenehmigung) for the VBC facilities.Reorganization of the enterprise for the implementation of a Quality Management System according to EN ISO 9001:2000 and ISO 13485 in compliance with the European and national regulations for the production of in vitro diagnostics

Vienna, Austria

Head of Downstream Production within the biotech production; Production of recombinant proteins for pharmaceutical purposes in industrial scale under cGMP; Project manager within international cooperation concerning contract manufacturing; contribution in several international contract manufacturing projectsBudget responsibilityResponsible for 28 employees

Vienna, Austria

Establishment of the group Process Science to develop and implement fermentation processes for the production of recombinant proteins in microorganisms for pharmaceutical applications. Planning implementation and expansion of adequate laboratories for the set tasks.Development of an automated analytical system for the online detection of metabolic fermentation parameters promoted by the FFF (today FFG). Graduation as Dr. rer. Nat. in Nov. 1998Budget responsibilityResponsible for 2 Employees 1994Consigned with 18 employees 2000

Vienna, Austria

Diploma theses at the Group anti-retroviral therapySubject: „Scanning mutagenesis of the arginine-rich region of the human immunodeficiency virus type 1 Rev trans activator“